Urgo Consumer Healthcare, growth, innovation, international expansion

With three leading brands: Urgo®, France’s best-selling dressing, Humex®, No. 1 in the upper respiratory tract infection market, and Alvityl®, which tops the children’s vitamin supplement market, Urgo Consumer Healthcare continues to grow thanks to a dynamic innovation policy.

Voted most innovative OTC company in pharmacies in 2008 and revelation of the year at the BFM Awards, Urgo Consumer Healthcare has implemented an original development process designed to bring new products to market quickly. Products that are under two years old account for 22% of its total sales.

With its Filmogel® technology, Urgo is the first pharmaceutical company to have launched a range of liquid dressings:

  • Urgo® Mouth Ulcers, the first dressing for the mouth, which has reached the Number 2 spot in France in just two years;
  • Urgo® Skin Cracks, the leading treatment for chapped and cracked skin;
  • Urgo® Damaged Nails, winner of the Direct Médica trophy for innovation in 2009 for the best retail pharmacy product launch.

A pioneer in the self-service pharmacy segment, Urgo Consumer Healthcare Healthcare is recognised as the company that has best supported pharmacists in this field.

Anticipating and meeting the needs of its customers is a golden rule at Urgo Consumer Healthcare.

Internationally, Urgo Consumer Healthcare has a strong position in 25 countries and its ultimate aim is to reach the No. 1 spot in all its reference markets in Europe..

 

Urgo Medical, leader of the French wound healing market, out to conquer Europe

Supported by its healing expertise as well as its constant attentiveness to and sound knowledge of both health professionals and patients, Urgo Medical develops high-tech medical solutions for treatments tailored to the various problems encountered in the prevention and treatment of wounds and tissue damage.

In 2000, Urgo Medical revolutionised the wound healing market market by inventing Lipido-Colloid Technology, which gave rise to Urgotul®. In 2007, it did the same again with Cellostart®, the first dressing to restart the healing process.

The leader in France and Germany, Urgo Medical is also the fourth-placed company in the European wound care market as a whole.

Urgo Medical has a second area of expertise: compression systems. Currently No. 1 in the UK compression bandage market, this activity is set to be extended to the whole of Europe, starting with Germany and the Netherlands.

By gaining a foothold in new regions and continuing its intensive research and development programme, Urgo Medical is determined to become the European wound care sector leader..

Go to urgomedical.com